Ticker
NTLACompany Name
INTELLIA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 898.89M | $ 102.59M | 11.41% |
3/31/2025 | $ 986.16M | $ 119.25M | 12.09% |
12/31/2024 | $ 1.19B | $ 210.2M | 17.65% |
9/30/2024 | $ 1.17B | $ 101.62M | 8.66% |
6/30/2024 | $ 1.19B | $ 106.3M | 8.92% |
3/31/2024 | $ 1.26B | $ 110.86M | 8.8% |
12/31/2023 | $ 1.3B | $ 115.35M | 8.87% |
9/30/2023 | $ 1.24B | $ 118.34M | 9.52% |
6/30/2023 | $ 1.32B | $ 122.33M | 9.24% |
3/31/2023 | $ 1.42B | $ 126.13M | 8.9% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for INTELLIA THERAPEUTICS INC is calculated as follows: Debt [ $ 22.2M ] / Assets [ $ 458.56M ]
(=) Debt to Assets [ 4.84% ]
Minimum
Sep 30, 2020
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.32% |
median | 21.04% |
std | 24.51% |